Lineage Cell Therapeutics, Inc. (LCTX)
1.71
-0.05
(-2.84%)
USD |
NYAM |
Jan 09, 16:00
1.72
+0.01
(+0.58%)
Pre-Market: 20:00
Lineage Cell Therapeutics Price: 1.71 for Jan. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ocugen, Inc. | 1.50 |
| Belite Bio, Inc. | 158.36 |
| ProKidney Corp. | 2.34 |
| CEL-SCI Corp. | 5.48 |
| AIM ImmunoTech, Inc. | 1.29 |
Price Related Metrics
| PS Ratio | 35.72 |
| PEG Ratio | -0.034 |
| Price to Book Value | 17.87 |
| Earnings Yield | -17.34% |
| Market Cap | 393.86M |
| PEGY Ratio | -0.034 |